이상반응 보고
| VAERS ID | 2217120 |
|---|---|
| 성별 | 여성 |
| 나이 | 93세 |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | ACB4447 |
| 예방접종 횟수 | 3 |
| 접종일 | 2022-01-06 |
| 발병일 | 2022-01-06 |
| 상태 | 중증 사망 |
증상
- 호흡곤란(Dyspnoea)
- 불안(Anxiety)
- 빈맥(Tachycardia)
- 심근 경색증(Myocardial infarction)
- 죽음(Death)
이환 중 질병
Cardiac insufficiency; Hypertension; Renal insufficiency
지병
Medical History/Concurrent Conditions: Protein allergy; Vein disorder
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Unknown cause of death; severe heart attacks; Shortness of breath; Tachycardia; anxiety; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the Regulatory Authority.
Regulatory number: DE-PEI-CADR2022286864.
Other Case identifier(s): DE-CADRPEI-2022286864, DE-PEI-202200094882.
A 93 year-old female patient received bnt162b2 (COMIRNATY), administration date 06Jan2022 (Lot number: ACB4447) at the age of 93 years as dose 3 (booster), single for covid-19 immunisation.
Relevant medical history included: "Renal insufficiency" (ongoing); "Cardiac insufficiency" (ongoing); "Hypertension" (ongoing); "protein allergy" (unspecified if ongoing); "vein disorder" (unspecified if ongoing).
The patient's concomitant medications were not reported.
Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for Covid-19 immunisation; Covid-19 vaccine (Dose 2, manufacturer unknown), for Covid-19 immunisation.
The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "Unknown cause of death"; MYOCARDIAL INFARCTION (death, medically significant) with onset 06Jan2022, outcome "fatal", described as "severe heart attacks"; DYSPNOEA (death) with onset 06Jan2022, outcome "fatal", described as "Shortness of breath"; TACHYCARDIA (life threatening) with onset 06Jan2022, outcome "unknown", described as "Tachycardia"; ANXIETY (life threatening) with onset 06Jan2022, outcome "unknown", described as "anxiety".
The events "severe heart attacks" and "shortness of breath" were evaluated at the emergency room visit.
The patient date of death was unknown.
The reported cause of death was "Unknown cause of death", myocardial infarction, dyspnoea.
It was not reported if an autopsy was performed.
The clinical course was reported as follows: 15 minutes after the booster injection, severe heart attacks, shortness of breath, anxiety.
Before administration of Biontec Booster, the patient (mother) was probably up, 15 minutes later acutely described.
The shortness of breath, heart attack determined by emergency doctor.
Relatedness of drug to reactions/events, Source of assessment: RA Result of Assessment: D.
Unclassifiable.
No follow-up attempts are possible.
No further information is expected.
; Reported Cause(s) of Death: shortness of breath; Unknown cause of death; severe heart attacks